Correlation Between GH Research and SAB Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GH Research and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GH Research and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GH Research PLC and SAB Biotherapeutics, you can compare the effects of market volatilities on GH Research and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GH Research with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GH Research and SAB Biotherapeutics.

Diversification Opportunities for GH Research and SAB Biotherapeutics

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GHRS and SAB is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding GH Research PLC and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and GH Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GH Research PLC are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of GH Research i.e., GH Research and SAB Biotherapeutics go up and down completely randomly.

Pair Corralation between GH Research and SAB Biotherapeutics

Given the investment horizon of 90 days GH Research PLC is expected to generate 0.65 times more return on investment than SAB Biotherapeutics. However, GH Research PLC is 1.55 times less risky than SAB Biotherapeutics. It trades about 0.04 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.02 per unit of risk. If you would invest  838.00  in GH Research PLC on November 27, 2024 and sell it today you would earn a total of  383.00  from holding GH Research PLC or generate 45.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GH Research PLC  vs.  SAB Biotherapeutics

 Performance 
       Timeline  
GH Research PLC 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in GH Research PLC are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, GH Research unveiled solid returns over the last few months and may actually be approaching a breakup point.
SAB Biotherapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days SAB Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

GH Research and SAB Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GH Research and SAB Biotherapeutics

The main advantage of trading using opposite GH Research and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GH Research position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.
The idea behind GH Research PLC and SAB Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios